サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1526402

E型肝炎診断検査の世界市場、規模、シェア、動向、産業分析レポート：検査タイプ別、最終用途別、地域別 - 市場予測、2024年～2032年

Global Hepatitis E Diagnostic Tests Market Size, Share, Trends, Industry Analysis Report: Information By Test Type, By End User, and By Region - Market Forecast, 2024 - 2032

出版日
ページ情報
英文 118 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
E型肝炎診断検査の世界市場、規模、シェア、動向、産業分析レポート：検査タイプ別、最終用途別、地域別 - 市場予測、2024年～2032年
出版日: 2024年07月01日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のE型肝炎診断検査市場規模は2032年までに7,862万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

世界のE型肝炎診断検査市場は、特に劣悪な衛生環境と水質汚染が蔓延している発展途上地域におけるE型肝炎の罹患率の上昇により成長を遂げています。PCRベースのアッセイやPOC検査キットなどの診断技術の進歩により、早期発見と疾病管理が向上しています。この市場の主な促進要因は、より効果的な診断ソリューションが求められるE型肝炎の有病率の増加、および疾病予防と管理に対する認識と政府の取り組みの高まりです。注目すべき動向としては、先進的な分子診断薬の採用や、新興市場における診断サービスの拡大が挙げられ、利用しやすさと手頃な価格での提供が強化されています。

競合分析では、Abbott LaboratoriesとRocheが、その広範なポートフォリオと新興国市場と先進国市場の両方における強力なプレゼンスによって際立っています。

全体として、E型肝炎診断検査市場は、技術革新、アクセシビリティの重視、世界の負担増への対応によって特徴付けられ、ヘルスケア業界の中でもダイナミックで急速に発展している分野となっています。

E型肝炎診断検査市場レポートハイライト

予測期間中、ELISA HEV IgM検査セグメントが市場を独占しています。この優位性は、感染に反応して産生されるIgM抗体の存在を同定するため、急性E型肝炎感染の検出に広く使用されていることに起因します。

RT-PCRセグメントは、今後数年間、市場で最も成長する分野です。この成長の背景には、HEV RNAの存在を検出し、感染の早期かつ正確な診断を可能にする高感度で特異的な診断ツールに対する需要の増加があります。

病院は、その広範なインフラ、高度な診断機器の利用可能性、診断サービスを必要とする患者の多さなどが主な理由です。

POCセグメントは、市場で最も高い成長を遂げているセグメントです。この急成長の背景には、便利で迅速な診断ソリューションに対する需要の高まりがあります。

北米が市場を独占し、アジア太平洋が最も高い成長率を示すと予想されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のE型肝炎診断検査市場の洞察

  • アプリケーションスナップショット
  • E型肝炎診断検査市場力学
    • 促進要因と機会
      • 診断技術の進歩
      • 新興市場への進出
    • 抑制要因と課題
      • 高コスト
  • PESTEL分析
  • E型肝炎診断検査市場のアプリケーション動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のE型肝炎診断検査市場：検査タイプ別

  • 主な調査結果
  • イントロダクション
  • ELISA HEV IgM検査
  • ELISA HEV IgG検査
  • 迅速診断検査
  • RT-PCR

第6章 世界のE型肝炎診断検査市場：最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院

第7章 世界のE型肝炎診断検査市場：地域別

  • 主な調査結果
  • イントロダクション
    • E型肝炎診断検査市場評価：地域別、2019年～2032年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • DiaSorin S.p.A.
  • Perkin Elmer Inc.
  • QIAGEN N.V.
  • bioMerieux SA
  • Merck KGaA
  • Ortho Clinical Diagnostics
  • InBios International
  • Altona Diagnostics
  • Luminex Corporation
  • Randox Laboratories
図表

List of Tables:

  • Table 1 Global Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 2 Global Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 3 North America: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 4 North America: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 5 U.S.: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 6 U.S.: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 7 Canada: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 8 Canada: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 9 Europe: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 10 Europe: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 11 UK: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 12 UK: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 13 France: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 14 France: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 15 Germany: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 16 Germany: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 17 Italy: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 18 Italy: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 19 Spain: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 20 Spain: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 21 Netherlands: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 22 Netherlands: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 23 Russia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 24 Russia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 25 Rest of Europe: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 26 Rest of Europe: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 28 Asia Pacific: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 29 China: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 30 China: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 31 India: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 32 India: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 33 Malaysia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 34 Malaysia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 35 Japan: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 36 Japan: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 37 Indonesia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 38 Indonesia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 39 South Korea: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 40 South Korea: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 41 Australia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 42 Australia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 43 Rest of Asia Pacific: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 44 Rest of Asia Pacific: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 45 Middle East & Africa: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 46 Middle East & Africa: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 47 Saudi Arabia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 48 Saudi Arabia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 49 UAE: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 50 UAE: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 51 Israel: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 52 Israel: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 53 South Africa: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 54 South Africa: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 55 Rest of Middle East & Africa: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 56 Rest of Middle East & Africa: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 57 Latin America: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 58 Latin America: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 59 Mexico: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 60 Mexico: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 61 Brazil: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 62 Brazil: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 63 Argentina: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 64 Argentina: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • Table 65 Rest of Latin America: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • Table 66 Rest of Latin America: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)

List of Figures:

  • Figure 1. Global Hepatitis E Diagnostic Tests Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Tests Type
  • Figure 7. Global Hepatitis E Diagnostic Tests Market, by Tests Type, 2023 & 2032 (USD Million)
  • Figure 8. Market by End Use
  • Figure 9. Global Hepatitis E Diagnostic Tests Market, by End Use, 2023 & 2032 (USD Million)
  • Figure 10. Global Hepatitis E Diagnostic Tests Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11. Strategic Analysis - Global Hepatitis E Diagnostic Tests Market
目次
Product Code: PM4998

The global Hepatitis E diagnostic tests market size is expected to reach USD 78.62 million by 2032, according to a new study by Polaris Market Research. The report "Global Hepatitis E Diagnostic Tests Market Size, Share, Trends, Industry Analysis Report: By Test Type (ELISA HEV IgM Test, ELISA HEV IgG Test, Rapid Diagnostics Test, and RT-PCR), By End User (Hospitals, Diagnostic Laboratories, Research Centers, and Point-of-Care), And By Region (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) - Market Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global Hepatitis E diagnostic tests market is experiencing growth due to the rising incidence of Hepatitis E, especially in developing regions where poor sanitation and water contamination are prevalent. Advances in diagnostic technologies, such as PCR-based assays and point-of-care testing kits, are improving early detection and disease management. Major drivers of this market are the increasing prevalence of Hepatitis E, which demands more effective diagnostic solutions, and the growing awareness and governmental efforts towards disease prevention and control. Notable trends include the adoption of advanced molecular diagnostics and the expansion of diagnostic services in emerging markets to enhance accessibility and affordability.

In terms of competitive analysis, Abbott Laboratories and Roche stand out due to their extensive portfolios and strong presence in both developed and emerging markets.

Overall, the Hepatitis E diagnostic tests market is characterized by technological innovation, a focus on accessibility, and a response to the growing global burden of the disease, making it a dynamic and rapidly evolving sector within the healthcare industry.

Hepatitis E Diagnostic Tests Market Report Highlights:

The ELISA HEV IgM test segment is dominating the market during forecast period. This dominance is attributed to its widespread use in detecting acute Hepatitis E infection, as it identifies the presence of IgM antibodies produced in response to the infection.

RT-PCR segment is the highest-growing segment within the market during upcoming years. This growth is driven by the increasing demand for highly sensitive and specific diagnostic tools that can detect the presence of HEV RNA, enabling early and accurate diagnosis of the infection.

Hospitals are the dominating segment in this market, primarily due to their extensive infrastructure, availability of advanced diagnostic equipment, and a high volume of patients requiring diagnostic services.

The Point-of-Care segment is the highest-growing segment within the market. This rapid growth is fueled by the increasing demand for convenient and quick diagnostic solutions.

North America dominates the market, while Asia-Pacific is expected to witness the highest growth rate.

Polaris Market Research has segmented the Hepatitis E diagnostics tests market report based on test type, end user, and region:

Hepatitis E Diagnostic Tests, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • ELISA HEV IgM Test
  • ELISA HEV IgG Test
  • Rapid Diagnostics Test
  • RT-PCR

Hepatitis E Diagnostic Tests, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Diagnostic Laboratories
  • Research Centers
  • Point-of-Care

Hepatitis E Diagnostic Tests, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Hepatitis E Diagnostic Tests Market Insights

  • 4.1. Hepatitis E Diagnostic Tests Market - Application Snapshot
  • 4.2. Hepatitis E Diagnostic Tests Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Diagnostic Technologies
      • 4.2.1.2. Expansion in Emerging Markets
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Hepatitis E Diagnostic Tests Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Hepatitis E Diagnostic Tests Market, by Tests Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
  • 5.3. ELISA HEV IgM Test
    • 5.3.1. Global Hepatitis E Diagnostic Tests Market, by ELISA HEV IgM Test, by Region, 2019-2032 (USD Million)
  • 5.4. ELISA HEV IgG Test
    • 5.4.1. Global Hepatitis E Diagnostic Tests Market, by ELISA HEV IgG Test, by Region, 2019-2032 (USD Million)
  • 5.5. Rapid Diagnostics Test
    • 5.5.1. Global Hepatitis E Diagnostic Tests Market, by Rapid Diagnostics Test, by Region, 2019-2032 (USD Million)
  • 5.6. RT-PCR
    • 5.6.1. Global Hepatitis E Diagnostic Tests Market, by RT-PCR, by Region, 2019-2032 (USD Million)

6. Global Hepatitis E Diagnostic Tests Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Global Hepatitis E Diagnostic Tests Market, by Hospitals, by Region, 2019-2032 (USD Million)
    • 6.3.2. Diagnostic Laboratories
      • 6.3.2.1. Global Hepatitis E Diagnostic Tests Market, by Diagnostic Laboratories, by Region, 2019-2032 (USD Million)
    • 6.3.3. Research Centers
      • 6.3.3.1. Global Hepatitis E Diagnostic Tests Market, by Research Centers, by Region, 2019-2032 (USD Million)
    • 6.3.4. Point-of-Care
      • 6.3.4.1. Global Hepatitis E Diagnostic Tests Market, by Point-of-Care, by Region, 2019-2032 (USD Million)

7. Global Hepatitis E Diagnostic Tests Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Hepatitis E Diagnostic Tests Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Hepatitis E Diagnostic Tests Market - North America
    • 7.3.1. North America: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
    • 7.3.2. North America: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.3.3. Hepatitis E Diagnostic Tests Market - U.S.
      • 7.3.3.1. U.S.: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.3.4. Hepatitis E Diagnostic Tests Market - Canada
      • 7.3.4.1. Canada: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • 7.4. Hepatitis E Diagnostic Tests Market - Europe
    • 7.4.1. Europe: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
    • 7.4.2. Europe: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.4.3. Hepatitis E Diagnostic Tests Market - UK
      • 7.4.3.1. UK: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.4.4. Hepatitis E Diagnostic Tests Market - France
      • 7.4.4.1. France: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.4.4.2. France: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.4.5. Hepatitis E Diagnostic Tests Market - Germany
      • 7.4.5.1. Germany: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.4.6. Hepatitis E Diagnostic Tests Market - Italy
      • 7.4.6.1. Italy: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.4.7. Hepatitis E Diagnostic Tests Market - Spain
      • 7.4.7.1. Spain: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.4.8. Hepatitis E Diagnostic Tests Market - Netherlands
      • 7.4.8.1. Netherlands: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.4.9. Hepatitis E Diagnostic Tests Market - Russia
      • 7.4.9.1. Russia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.4.10. Hepatitis E Diagnostic Tests Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.4.10.2. Rest of Europe: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • 7.5. Hepatitis E Diagnostic Tests Market - Asia Pacific
    • 7.5.1. Asia Pacific: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.5.3. Hepatitis E Diagnostic Tests Market - China
      • 7.5.3.1. China: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.5.3.2. China: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.5.4. Hepatitis E Diagnostic Tests Market - India
      • 7.5.4.1. India: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.5.4.2. India: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.5.5. Hepatitis E Diagnostic Tests Market - Malaysia
      • 7.5.5.1. Malaysia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.5.6. Hepatitis E Diagnostic Tests Market - Japan
      • 7.5.6.1. Japan: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.5.7. Hepatitis E Diagnostic Tests Market - Indonesia
      • 7.5.7.1. Indonesia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.5.8. Hepatitis E Diagnostic Tests Market - South Korea
      • 7.5.8.1. South Korea: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.5.9. Hepatitis E Diagnostic Tests Market - Australia
      • 7.5.9.1. Australia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.5.9.2. Australia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.5.10. Hepatitis E Diagnostic Tests Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.5.10.2. Rest of Asia Pacific: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • 7.6. Hepatitis E Diagnostic Tests Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.6.3. Hepatitis E Diagnostic Tests Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.6.4. Hepatitis E Diagnostic Tests Market - UAE
      • 7.6.4.1. UAE: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.6.5. Hepatitis E Diagnostic Tests Market - Israel
      • 7.6.5.1. Israel: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.6.6. Hepatitis E Diagnostic Tests Market - South Africa
      • 7.6.6.1. South Africa: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.6.7. Hepatitis E Diagnostic Tests Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.6.7.2. Rest of Middle East & Africa: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
  • 7.7. Hepatitis E Diagnostic Tests Market - Latin America
    • 7.7.1. Latin America: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.7.3. Hepatitis E Diagnostic Tests Market - Mexico
      • 7.7.3.1. Mexico: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.7.4. Hepatitis E Diagnostic Tests Market - Brazil
      • 7.7.4.1. Brazil: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.7.5. Hepatitis E Diagnostic Tests Market - Argentina
      • 7.7.5.1. Argentina: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
    • 7.7.6. Hepatitis E Diagnostic Tests Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
      • 7.7.6.2. Rest of Latin America: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. F. Hoffmann-La Roche Ltd
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Siemens Healthineers
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Bio-Rad Laboratories
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Thermo Fisher Scientific
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. DiaSorin S.p.A.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Perkin Elmer Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. QIAGEN N.V.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. bioMerieux SA
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Merck KGaA
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Ortho Clinical Diagnostics
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. InBios International
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Altona Diagnostics
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Luminex Corporation
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Randox Laboratories
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development